Previsioni di mercato per la terapia dell\'osteoartrosi in Sud e Centro America fino al 2030 - Analisi regionale - per tipo di terapia (stimolazione elettrica transcutanea dei nervi (TENS), terapia occupazionale, terapia fisica, terapia al plasma ricco di piastrine e frazione vascolare stromale, proloterapia e altri), indicazione della malattia (Osteoartrite del ginocchio, Osteoartrite della colonna vertebrale, Osteoartrite del piede e della caviglia, Osteoartrite della spalla, Osteoartrite della mano e altri) e Utente finale (Ospedali e cliniche, Cliniche specialistiche, Centri chirurgici ambulatoriali, Assistenza domiciliare e Altri)

BMIRE00030556 | Pages: 90 | Medical Device | Jul 2024 | Type: Regional | Status: Published
Il mercato della terapia per l’osteoartrite in Sud e Centro America è stato valutato a 345,44 milioni di dollari nel 2022 e si prevede che raggiungerà 552,40 milioni di dollari entro il 2030; si stima registrerà un CAGR del 6,0% dal 2022 al 2030.

Opzioni terapeutiche più efficaci alimentano il mercato della terapia per l\'osteoartrosi in America meridionale e centrale.

Attualmente non esiste una cura per l\'OA. Un gruppo di ricercatori clinici, attraverso studi clinici, rivela che stanno sviluppando opzioni terapeutiche innovative che possono fermare la progressione dell\'OA. Ad esempio, nel novembre 2021, la società LG Chem ha annunciato l’avvio di una sperimentazione clinica per nuovi farmaci di prossima generazione per il trattamento dell’artrite. Inoltre, nell\'ottobre 2021, Pacira BioSciences, Inc. ha annunciato l\'acquisizione di Flexion Therapeutics per il trattamento del dolore non oppioide \"ZILRETTA\". Il farmaco approvato nel 2017 è il primo e unico trattamento approvato per il dolore al ginocchio da OA che utilizza la tecnologia delle microsfere a rilascio prolungato.

Nel settembre 2023, Sorrento Therapeutics, Inc. ha annunciato risultati positivi della sperimentazione clinica di Fase 2 per il \"programma Resiniferatossina (RTX)\". Lo studio di Fase 2 è uno studio multicentrico, in doppio cieco, con placebo e con controllo attivo che valuta l\'efficacia e la sicurezza di diversi gruppi di dosaggio di RTX per gestire il dolore nei pazienti con OAK da moderata a grave. Inoltre, Sorrento ha deciso di includere un farmaco concorrente attivo approvato, \"Zilretta\", nell\'attuale protocollo di sperimentazione clinica.

Panoramica del mercato della terapia per l\'osteoartrosi in America meridionale e centrale.

I paesi dell\'America meridionale e centrale comprendono Brasile, Argentina e il resto dell\'America meridionale e centrale. Il lancio di nuovi prodotti da parte dei produttori per rimanere all’avanguardia nel mercato competitivo è un fattore significativo responsabile della crescita del mercato nella regione del Sud e Centro America. Secondo il rapporto Researchgate, in Brasile, la prevalenza dell’osteoartrosi è del 33% tra gli individui di età superiore ai 25 anni, con un numero stimato di 40 milioni di persone affette da questo disturbo. Inoltre, il rapporto della Korea Knee Society rivela che l’osteoartrosi colpisce circa il 4% della popolazione adulta in Brasile. Il lancio di nuovi prodotti da parte dei produttori per rimanere all’avanguardia nel mercato competitivo è un fattore significativo responsabile della crescita del mercato. Ad esempio, nell\'ottobre 2018, Bioventus ha annunciato l\'approvazione per \"DUROLANE\" da parte dell\'Agência Nacional de Vigilância Sanitária (ANVISA). Il prodotto appena lanciato è una singola iniezione per il trattamento dell’OA in Brasile. ANVISA ha approvato DUROLANE per il trattamento sintomatico dell\'OA del ginocchio e dell\'anca da lieve a moderata. Pertanto, il lancio di prodotti innovativi in Brasile per il trattamento dell’osteoartrite alimenta la crescita del mercato.

Entrate e previsioni del mercato della terapia per l\'osteoartrite in Sud e America Centrale fino al 2030 (milioni di dollari)

Segmentazione del mercato della terapia per l\'osteoartrite in Sud e America Centrale

La terapia per l\'osteoartrosi in America del Sud e Centro il mercato è classificato in tipo di terapia, indicazioni di malattia, utente finale e paese.

In base al tipo di terapia, il mercato della terapia per l\'osteoartrite in Sud e Centro America è segmentato in stimolazione nervosa elettrica transcutanea (TENS), terapia occupazionale, terapia fisica, terapia con plasma ricco di piastrine (PRP) e frazione vascolare stromale, proloterapia , e altri. Il segmento della terapia fisica ha detenuto la quota di mercato maggiore nel 2022.

In termini di indicazioni patologiche, il mercato della terapia per l\'osteoartrosi dell\'America centrale e meridionale è segmentato in osteoartrosi del ginocchio, artrosi della colonna vertebrale, artrosi del piede e della caviglia, artrosi della spalla, artrosi della mano osteoartrite e altri. Il segmento dell\'osteoartrite del ginocchio ha detenuto la quota maggiore dell\'America meridionale e centrale nel 2022.

In base all\'utente finale, il mercato della terapia per l\'osteoartrosi dell\'America centrale e meridionale è classificato in ospedali e cliniche, cliniche specializzate, centri chirurgici ambulatoriali, assistenza domiciliare , e altri. Il segmento dell\'assistenza domiciliare deteneva la quota maggiore dell\'America meridionale e centrale nel 2022.

Per paese, il mercato della terapia per l\'osteoartrosi dell\'America meridionale e centrale è segmentato in Brasile, Argentina e il resto dell\'America meridionale e centrale. Il Brasile ha dominato la quota dell\'America meridionale e centrale nel 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc e Omron Healthcare Inc sono alcune delle aziende leader che operano nel mercato della terapia per l\'osteoartrosi dell\'America meridionale e centrale.

TABLE OF CONTENTS

 

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis

4.1.1 Clinical Trial Pipeline Analysis

5. South & Central America Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers

5.1.1 Rising Prevalence of Osteoarthritis

5.1.2 Innovative Therapy Options Reducing Dependency on Medications

5.2 Market Restraints

5.2.1 Product Recall

5.3 Market Opportunities

5.3.1 Availability of Regenerative Medicine

5.4 Future Trends

5.4.1 More Effective Treatment Options

5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - South & Central America Market Analysis

6.1 Overview

6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. South & Central America Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview

7.2 Transcutaneous Electrical Nerve Stimulation (TENS)

7.2.1 Overview

7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.3 Occupational Therapy

7.3.1 Overview

7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Physical Therapy

7.4.1 Overview

7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction

7.5.1 Overview

7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Prolotherapy

7.6.1 Overview

7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview

8.2 Knee Osteoarthritis

8.2.1 Overview

8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.3 Spine Osteoarthritis

8.3.1 Overview

8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Foot and Ankle Osteoarthritis

8.4.1 Overview

8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Shoulder Osteoarthritis

8.5.1 Overview

8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.6 Hand Osteoarthritis

8.6.1 Overview

8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview

9.2 Hospitals and Clinics

9.2.1 Overview

9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.3 Specialty Clinics

9.3.1 Overview

9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.4 Ambulatory Surgical Centers

9.4.1 Overview

9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.5 Homecare

9.5.1 Overview

9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9.6 Others

9.6.1 Overview

9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Osteoarthritis Therapy Market - Country Analysis

10.1 South & Central America Market Overview

10.1.1 South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country

10.1.1.1 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User

10.1.1.3 Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.3 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type

10.1.1.3.4 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication

10.1.1.3.5 Rest of South & Central America: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview

11.2 Growth Strategies in the osteoarthritis therapy market

11.3 Organic Developments

11.3.1 Overview

11.4 Inorganic Developments

11.4.1 Overview

12. Company Profiles

12.1 Zimmer Biomet Holdings Inc

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 DePuy Synthes Inc

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Bioventus Inc

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Omron Healthcare Inc

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

13. Appendix

13.1 About the Insight Partners

List of Tables

Table 1. Osteoarthritis Therapy Market Segmentation

Table 2. Ongoing Clinical Trial of Osteoarthritis

Table 3. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 4. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 5. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 6. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 7. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 8. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 9. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type

Table 10. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication

Table 11. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User

Table 12. Organic Developments Done by Companies

Table 13. Inorganic Developments Done by Companies

List of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country

Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics

Figure 3. Impact Analysis of Drivers and Restraints

Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)

Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)

Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)

Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. South & Central America: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)

Figure 26. South & Central America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)

Figure 27. Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 28. Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 29. Rest of South & Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)

Figure 30. Growth Strategies in the Osteoarthritis Therapy Market

1. Zimmer Biomet Holdings Inc 
2. DePuy Synthes Inc 
3. Bioventus Inc 
4. Omron Healthcare Inc 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America osteoarthritis therapy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America osteoarthritis therapy market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3550
$2840
Site License
$4550
$3640
Enterprise License
$5550
$4440